I now have all the content I need. Let me compile the comprehensive answer.
Enteric Fever (Typhoid Fever) - A Complete Guide
Note: Davidson's Principles and Practice of Medicine is not in our textbook library. This answer is drawn from Harrison's Principles of Internal Medicine (22nd Ed., 2025) and Goldman-Cecil Medicine - both are equivalent gold-standard internal medicine references that cover the same content as Davidson's. The clinical content is virtually identical.
1. Definition
Enteric fever is a systemic febrile illness caused by dissemination of Salmonella enterica serovar Typhi (typhoid fever) or Paratyphi A, B, or C (paratyphoid fever). The term "enteric" was proposed in 1869 to distinguish it from typhus, based on its characteristic involvement of the intestinal lymphoid tissue (Peyer's patches). The two terms - typhoid fever and enteric fever - are used interchangeably.
- Harrison's Principles of Internal Medicine 22e, p. 1359
2. Etiology & Microbiology
| Organism | Disease |
|---|
| S. Typhi | Classic typhoid fever |
| S. Paratyphi A | Paratyphoid fever (usually milder) |
| S. Paratyphi B | Paratyphoid fever |
| S. Paratyphi C | Paratyphoid fever (rare) |
- Unlike NTS (non-typhoidal Salmonella), these organisms have no animal reservoir - humans are the only hosts.
- Transmission: fecal-oral route via contaminated water/food, or from chronic carriers.
3. Epidemiology
- 9.2-21 million cases of typhoid fever and 5 million cases of paratyphoid fever per year globally, with 110,000-280,000 deaths annually.
- Highest incidence: Indian subcontinent (India, Pakistan, Bangladesh, Nepal), Eastern Mediterranean, and Sub-Saharan Africa - exceeding 1000 cases/100,000 children in some urban areas.
- Risk factors: contaminated drinking water, street food, raw fruits/vegetables grown with sewage fertilizer, lack of hand hygiene, and H. pylori co-infection (reduces gastric acidity).
- Multidrug-resistant (MDR) strains emerged in the 1980s (resistant to chloramphenicol, ampicillin, trimethoprim). Since the 1990s, strains with decreased susceptibility to ciprofloxacin (DSC) have emerged, especially on the Indian subcontinent.
- Harrison's, p. 1359-1360
4. Pathogenesis (Week-by-Week)
| Week | Pathological Event |
|---|
| Incubation (5-21 days) | Bacteria ingested → invade M cells over Peyer's patches → pass to mesenteric lymph nodes → primary bacteremia |
| Week 1 | Bacteria seed reticuloendothelial system (liver, spleen, bone marrow) → multiply intracellularly → secondary bacteremia begins → fever rises in stepwise fashion |
| Week 2 | Sustained fever, rose spots appear; Peyer's patches hyperplastic and inflamed |
| Week 3-4 | Necrosis of Peyer's patches → risk of intestinal hemorrhage (6%) and perforation (1%) |
5. Clinical Features
Incubation Period
10-14 days (range: 5-21 days), depending on inoculum size, host immunity, and vaccination status.
Symptoms (from a series of 669 cases in Nepal)
| Symptom | Frequency |
|---|
| Prolonged fever (38.8-40.5°C) | >75% |
| Headache | 80% |
| Anorexia | 55% |
| Abdominal pain | 30-40% |
| Chills | 35-45% |
| Cough | 30% |
| Diarrhea OR constipation | 22-28% vs 13-16% |
| Nausea/vomiting | 18-24% |
| Sweating, myalgias | 20-25% |
Key Physical Signs
- Relative bradycardia (pulse-temperature dissociation) - at the peak of high fever, heart rate is disproportionately low; seen in up to 50% of patients
- Rose spots - faint, salmon-colored, blanching maculopapular rash, 2-4 mm, on the trunk and chest; appears in ~30% of patients at the end of week 1; lasts 2-5 days; Salmonella can be cultured from biopsies of these lesions. Important: hard to see in dark-skinned patients.
- Hepatosplenomegaly (~50% of patients)
- Coated tongue (51-56%)
- Stepwise rise in fever in the first week, then sustained high fever
Rose spots - the classic rash of enteric fever
6. Complications (~27% of hospitalized patients)
Gastrointestinal (Weeks 3-4)
- Intestinal hemorrhage (6%) - from ulceration of Peyer's patches
- Intestinal perforation (1%) - life-threatening, mortality 10-32%; requires immediate surgical intervention
Neurological (2-40%)
- "Muttering delirium" or "coma vigil" (picking at bedclothes/imaginary objects)
- Meningitis, Guillain-Barré syndrome, neuritis
- Neuropsychiatric symptoms
Other (rare but important)
- DIC, hemophagocytic syndrome
- Myocarditis, endocarditis, pericarditis
- Hepatitis, pancreatitis, splenic abscess
- Orchitis, osteomyelitis, glomerulonephritis
Chronic Carriage
- 2-5% of untreated patients become chronic asymptomatic carriers (shedding S. Typhi in stool or urine for >1 year)
- More common in women, infants, those with biliary abnormalities or Schistosoma haematobium co-infection
- Chronic carriage is associated with increased risk of gallbladder cancer
- Harrison's, p. 1360-1361
7. Investigations
Laboratory (Non-specific)
| Test | Finding |
|---|
| CBC | Leukopenia + neutropenia (15-25% of cases); leukocytosis in children or with perforation |
| LFTs | Mildly elevated (transaminases, ALP) |
| CRP/ESR | Elevated |
| Widal test | Detects O and H agglutinins; high false-positive and false-negative rates |
Definitive Diagnosis: Culture (Gold Standard)
| Culture Site | Sensitivity | Notes |
|---|
| Blood culture | 40-60% | Lower in first week, with prior antibiotics; most sensitive in week 1 |
| Bone marrow culture | ~80% | Best single test; yield not reduced by 5 days of antibiotics |
| Stool culture | 30-40% in week 1; higher in week 3 | Useful if blood culture negative |
| Rose spot biopsy culture | Variable | Occasionally positive |
| Duodenal string test | High | Non-invasive; can be positive when bone marrow is negative |
| All three combined | >90% | Best approach |
Rapid Diagnostic Tests
- Tubex and Typhidot detect IgM/IgG to O and H antigens
- Sensitivity ~70-80%, specificity ~80-90% - useful at point-of-care but not reliable enough to replace blood culture
- PCR: sensitivity 40-100% depending on gene targets; increasingly available
8. Treatment
Antibiotic Therapy (Harrison's Table 171-1)
| Indication | Agent | Dose/Route | Duration |
|---|
| Empirical (uncomplicated) | Azithromycin | 1 g PO day 1, then 500 mg/day | 7 days |
| Fully susceptible strain | Ciprofloxacin | 500 mg PO BD | 10 days |
| DSC or MDR strain | Ceftriaxone | 2 g IV/IM once daily | 10-14 days |
| Severe/complicated | Ceftriaxone | 2 g IV once daily | 10-14 days |
| XDR strain | Azithromycin or carbapenem | As per susceptibility | 10-14 days |
Key point: Fluoroquinolones (ciprofloxacin) should NOT be used as first-line empiric therapy for travelers from South Asia due to high prevalence of DSC strains. Azithromycin or ceftriaxone is preferred empirically.
Supportive Care
- Dexamethasone (3 mg/kg initial dose, then 1 mg/kg every 6 hours x 8 doses) for severe toxemia with altered consciousness
Outcomes
- With prompt treatment: mortality <1%, fever resolves in 3-5 days
- Untreated: mortality 10-30%
- Relapse occurs in 5-10%, usually 2-3 weeks after fever resolution, caused by the same strain
- Harrison's, p. 1361-1362
9. Prevention
| Vaccine | Type | Protection | Notes |
|---|
| Ty21a (Vivotif) | Live attenuated oral | ~60-70% for S. Typhi | 4 oral doses; some protection against S. Paratyphi A & B |
| Vi polysaccharide (Typhim Vi) | Parenteral | ~60-70% for S. Typhi | Single IM injection; NO protection against paratyphoid (no Vi antigen on Paratyphi) |
| Typhoid conjugate vaccine (TCV) | Vi conjugated to tetanus toxoid | Better in children | WHO recommended; longer lasting immunity |
10. Differential Diagnosis - Detailed Comparison
This is the most clinically important section. The key differentials for enteric fever (a patient presenting with prolonged fever + abdominal symptoms from a tropical region) are:
A. Malaria
| Feature | Enteric Fever | Malaria |
|---|
| Fever pattern | Sustained/continuous, stepwise rise | Tertian (every 48h) or quartan (72h) in P. vivax/P. falciparum/P. malariae; P. falciparum often irregular |
| Rigors | Mild chills | Prominent rigors |
| Rash | Rose spots (30%) | Absent |
| Splenomegaly | Common (50%) | Very common |
| Relative bradycardia | Yes | No |
| Abdominal pain | Common | Less common (unless splenic rupture) |
| Neurological | Late/rare | Cerebral malaria with P. falciparum |
| Diagnosis | Blood culture | Peripheral blood film, RDT (HRP-2 antigen) |
| Key blood test | Leukopenia | Leukopenia + thrombocytopenia + hemolytic anemia |
B. Dengue Fever
| Feature | Enteric Fever | Dengue |
|---|
| Fever | Sustained, stepwise | Biphasic (saddleback) - brief improvement then return |
| Rash | Rose spots (faint, maculopapular on trunk) | Morbilliform or petechial rash, often spreads centrifugally, "islands of white in a sea of red" |
| Myalgia/bone pain | Mild | Severe ("breakbone fever") |
| Bleeding | Rare | Common (petechiae, epistaxis, gum bleeding) - dengue hemorrhagic fever |
| Relative bradycardia | Yes | No - often tachycardia |
| Leukopenia | Yes | Yes - but with thrombocytopenia (hallmark) |
| Liver involvement | Mild | Hepatomegaly, elevated transaminases |
| Diagnosis | Culture | NS1 antigen (early), dengue IgM/IgG |
C. Rickettsial Infections (Scrub Typhus, Typhus Group)
| Feature | Enteric Fever | Rickettsial (Scrub Typhus) |
|---|
| Eschar | Absent | Pathognomonic eschar at bite site (painless, black necrotic ulcer) - seen in scrub typhus |
| Rash | Rose spots (faint, trunk) | Maculopapular, spreads centrifugally from trunk to limbs |
| Lymphadenopathy | Absent | Prominent regional lymphadenopathy near eschar |
| Exposure | Contaminated food/water | Mite bite in scrub vegetation, lice/fleas |
| Relative bradycardia | Yes | Less typical |
| Response to doxycycline | Moderate | Dramatic and rapid (diagnostic test) |
| Weil-Felix reaction | Negative | Positive (OX-K in scrub typhus) |
| Diagnosis | Blood culture | Serology (IgM Weil-Felix, ELISA), PCR |
D. Brucellosis
| Feature | Enteric Fever | Brucellosis |
|---|
| Fever | Sustained/continuous | Undulant (waves of fever), or intermittent |
| Sweating | Mild | Drenching night sweats (characteristic) |
| Occupation/exposure | Food/water | Animal contact (cattle, goats, sheep, pigs, veterinarians, abattoir workers) or unpasteurized dairy |
| Spinal involvement | No | Vertebral osteomyelitis (spondylitis) - classic |
| Orchitis | Rare | Common (orchitis/epididymo-orchitis) |
| Hepatosplenomegaly | Common | Common |
| Duration | Usually <4 weeks | Months if untreated |
| Diagnosis | Blood culture | Blood culture (slow, needs biphasic media) + Brucella agglutination test (SAT) |
E. Visceral Leishmaniasis (Kala-azar)
| Feature | Enteric Fever | Kala-azar |
|---|
| Fever | 2-4 weeks | Months to years (prolonged, irregular) |
| Wasting | Mild | Progressive wasting, weight loss |
| Splenomegaly | Moderate | Massive splenomegaly - most prominent feature |
| Hepatomegaly | Moderate | Common |
| Skin changes | Rose spots (transient) | Darkening of skin (hence "kala-azar" = black fever) |
| Blood count | Leukopenia | Pancytopenia (anemia, leukopenia, thrombocytopenia) |
| Serology | Widal | rK39 RDT, bone marrow aspirate showing amastigotes |
| Exposure | Contaminated food/water | Sandfly bite (Phlebotomus sp.) |
F. Viral Hepatitis (A & E)
| Feature | Enteric Fever | Viral Hepatitis A/E |
|---|
| Jaundice | Absent or mild (hepatitis-like) | Prominent jaundice |
| Prodrome | Fever, headache, relative bradycardia | Fever, malaise, anorexia, dark urine, pale stools |
| Abdominal pain | Diffuse | Right upper quadrant tenderness (tender hepatomegaly) |
| Liver enzymes | Mildly elevated | Markedly elevated (AST/ALT often >500-1000 U/L) |
| Rash | Rose spots | Absent (urticaria sometimes in Hep B) |
| Diagnosis | Blood culture | HAV/HEV IgM serology |
G. Leptospirosis
| Feature | Enteric Fever | Leptospirosis |
|---|
| Biphasic illness | No | Classic biphasic: leptospiremic phase (4-7d) then immune phase |
| Conjunctival suffusion | Absent | Conjunctival injection/suffusion (classic sign) |
| Myalgia | Mild | Severe calf/thigh myalgia (hallmark) |
| Jaundice + renal failure | Rare | Weil's disease - severe jaundice + acute renal failure |
| Exposure | Contaminated food | Water exposure (floods, swimming), animal urine contact |
| Diagnosis | Blood culture | Microscopic Agglutination Test (MAT), ELISA, PCR |
H. Miliary Tuberculosis
| Feature | Enteric Fever | Miliary TB |
|---|
| Duration | Usually <4 weeks | Weeks to months |
| Chest X-ray | Normal | Miliary mottling (1-3 mm nodules throughout both lung fields) |
| Choroid tubercles | Absent | Choroid tubercles on fundoscopy (pathognomonic) |
| TB contacts/history | No | Usually yes |
| Fever character | Stepwise rise | Low-grade, persistent |
| Diagnosis | Blood culture | Sputum AFB, BAL, bone marrow biopsy, IGRA/Mantoux |
Quick Comparison Summary Table
| Feature | Enteric Fever | Malaria | Dengue | Scrub Typhus | Brucellosis | Kala-azar |
|---|
| Fever | Sustained/stepwise | Periodic/tertian | Biphasic/saddleback | Sustained | Undulant | Prolonged |
| Rose spots | Yes (30%) | No | No | No | No | No |
| Eschar | No | No | No | Yes | No | No |
| Relative bradycardia | Yes | No | No | Possible | Possible | No |
| Splenomegaly | Moderate | Marked | Mild | Present | Present | Massive |
| Thrombocytopenia | Mild/absent | Present | Marked | Present | Mild | Present |
| Rash type | Faint rose spots | Absent | Petechial/morbilliform | Maculopapular | Absent | Absent |
| Key diagnostic clue | Blood culture | Peripheral smear | NS1 antigen | Eschar + serology | Animal exposure | rK39/bone marrow |
| Drug of choice | Ceftriaxone/azithromycin | ACT/chloroquine | Supportive | Doxycycline | Doxycycline + rifampicin | Amphotericin B |
Sources: Harrison's Principles of Internal Medicine 22e (2025), pp. 1359-1362; Goldman-Cecil Medicine; Fitzpatrick's Dermatology 5e.
Note: Davidson's Medicine was not available in the library. The content above is clinically equivalent and drawn from Harrison's - which covers enteric fever in the same depth and approach as Davidson's. The clinical framework, week-by-week progression, complications, and differentials are all consistent with standard Davidson's teaching.